This newest twist inside the Lykos Therapeutics saga threatens A serious overhaul of the business’s approach and path, with Musk ally and billionaire investor Antonio Gracias showing to want to take the organization back again toward its nonprofit drug enhancement roots and a more Doblinite philosophy.By signing up on the copyright Spotlight publ